In Vitro - in Vivo Extrapolation of Hepatic Clearance in Preclinical Species
Authors:
- 7 March 2022
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 39 (7) , 1615-1632
Abstract
Accurate prediction of human clearance is of critical importance in drug discovery. In this study, in vitro – in vivo extrapolation (IVIVE) of hepatic clearance was established using large sets of compounds for four preclinical species (mouse, rat, dog, and non-human primate) to enable better understanding of clearance mechanisms and human translation. In vitro intrinsic clearances were obtained using pooled liver microsomes (LMs) or hepatocytes (HEPs) and scaled to hepatic clearance using the parallel-tube and well-stirred models. Subsequently, IVIVE scaling factors (SFs) were derived to best predict in vivo clearance. The SFs for extended clearance classification system (ECCS) class 2/4 compounds, involving metabolic clearance, were generally small (≤ 2.6) using both LMs and HEPs with parallel-tube model, with the exception of the rodents (~ 2.4–4.6), suggesting in vitro reagents represent in vivo reasonably well. SFs for ECCS class 1A and 1B are generally higher than class 2/4 across the species, likely due to the contribution of transporter-mediated clearance that is under-represented with in vitro reagents. The parallel-tube model offered lower variability in clearance predictions over the well-stirred model. For compounds that likely demonstrate passive permeability-limited clearance in vitro, rat LM predicted in vivo clearance more accurately than HEP. This comprehensive analysis demonstrated reliable IVIVE can be achieved using LMs and HEPs. Evaluation of clearance IVIVE in preclinical species helps to better understand clearance mechanisms, establish more reliable IVIVE in human, and enhance our confidence in human clearance and PK prediction, while considering species differences in drug metabolizing enzymes and transporters.Keywords
This publication has 44 references indexed in Scilit:
- Mechanistic insights from comparing intrinsic clearance values between human liver microsomes and hepatocytes to guide drug designEuropean Journal of Medicinal Chemistry, 2012
- Development of a new permeability assay using low‐efflux MDCKII cellsJournal of Pharmaceutical Sciences, 2011
- Prediction of Human Renal Clearance from Preclinical Species for a Diverse Set of Drugs That Exhibit Both Active Secretion and Net ReabsorptionDrug Metabolism and Disposition, 2011
- Measuring Agreement2010
- Modulation of the Partition Coefficient between Octanol and Buffer at pH 7.4 and p Ka to Achieve the Optimum Balance of Blood Clearance and Volume of Distribution for a Series of Tetrahydropyran Histamine Type 3 Receptor AntagonistsDrug Metabolism and Disposition, 2009
- Tautomer Enumeration and Stability Prediction for Virtual Screening on Large Chemical DatabasesJournal of Chemical Information and Modeling, 2009
- Measurement of Dissociation Constants (pKa Values) of Organic Compounds by Multiplexed Capillary Electrophoresis Using Aqueous and Cosolvent Buffers**Advanced Analytical Technologies, Inc. (Formerly CombiSep), 2711 South Loop Drive, Suite 4200, Ames, IA 50010.Journal of Pharmaceutical Sciences, 2008
- New and Original pKa Prediction Method Using Grid Molecular Interaction FieldsJournal of Chemical Information and Modeling, 2007
- Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and inductionExpert Opinion on Drug Metabolism & Toxicology, 2006
- ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral CompoundsJournal of Medicinal Chemistry, 2001